News

Transactions in Connection with Share Buy-back Program
Genmab A/S (Nasdaq: GMAB). On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce capital and to honor our commitments under ...
Climate Cosmos on MSN1d
Top 10 Environmental Sins of US Citizens
Are we doing enough to protect our planet? 🌍 Join me as we uncover the top 10 environmental sins committed by US citizens. Let's change our habits for a healthier Earth! #Sustainability #EcoAwareness ...
Leerink Raises Genmab (GMAB) Price Target, Keeps Outperform Rating
The updated data showed positive results and supports the company’s aim to start a Phase 111 trial later this year.
Morgan Stanley Keeps Their Hold Rating on Genmab (GMAB)
In a report released today, Vikram Purohit from Morgan Stanley maintained a Hold rating on Genmab (GMAB – Research Report), with a price target of $25.00. The company’s shares ...
UBS Sticks to Their Buy Rating for Genmab A/S (0MGB)
UBS analyst Xian Deng maintained a Buy rating on Genmab A/S ( 0MGB – Research Report) today and set a price target of DKK2,600.00. The company’s shares closed yesterday at DKK1,420.74.